Table 4.
Risk-Ratios of Incident Brain Infarcts (RR 95% CI) | ||||
---|---|---|---|---|
Potential Risk-Factor | Overall | Subcortical | Cortical | Cerebellar |
Age per 5 years | 1.45 (1.25–1.70) | 1.19 (0.99–1.43) | 1.59 (1.28–1.97) | 1.45 (1.24–1.69) |
Sex (men vs. women) | 1.83 (1.49–2.25) | 2.27 (1.54–3.33) | 2.85 (2.05–3.95) | 1.32 (1.03–1.70) |
Presence at Baseline (1+ vs 0) | 3.06 (2.50–3.75) | 5.76 (3.89–8.52) | 4.26 (3.00–6.06) | 2.96 (2.28–3.86) |
Hypertension (yes vs no) | 1.93 (1.21–3.07) | 1.40 (0.54–3.62) | 1.29 (0.61–2.76) | 3.27 (1.59–6.74) |
Systolic Blood Pressure | 1.09 (0.99–1.19) | 1.20 (1.03–1.40) | 1.02 (0.88–1.19) | 1.10 (0.99–1.23) |
Diastolic Blood pressure | 1.02 (0.90–1.16) | 1.29 (1.02–1.64) | 0.89 (0.72–1.10) | 1.04 (0.91–1.20) |
Diabetes Mellitus (yes vs no) | 1.21 (0.86–1.71) | 1.54 (0.92–2.60) | 1.03 (0.61–1.73) | 1.25 (0.85–1.82) |
Smoking (current vs never) | 1.00 (0.71–1.42) | 1.00 (0.53–1.88) | 0.84 (0.51–1.39) | 1.11 (0.70–1.75) |
Smoking (quit vs never) | 0.96 (0.76–1.21) | 0.94 (0.61–1.45) | 0.90 (0.62–1.29) | 1.01 (0.76–1.34) |
Atrial Fibrillation | 1.09 (0.73–1.64) | 0.64 (0.27–1.51) | 1.31 (0.68–2.52) | 1.07 (0.68–1.69) |
Carotid Plaque (≥mod plaque) | 1.27 (1.01–1.59) | 1.03 (0.68–1.57) | 1.93 (1.29–2.89) | 1.07 (0.81–1.40) |
Migraine (yes vs no) | 1.24 (0.94–1.63) | 0.79 (0.40–1.58) | 1.16 (0.72–1.88) | 1.40 (1.00–1.96) |
Migraine with aura (yes vs no) | 1.44 (0.96–2.16) | 1.19 (0.51–2.82) | 1.78 (0.98–3.24) | 1.33 (0.79–2.24) |
Use of lipid lowering medication (yes vs no) | 1.03 (0.81–1.31) | 0.92 (0.61–1.40) | 1.28 (0.89–1.84) | 0.92 (0.69–1.22) |
Total Cholesterol† | 0.95 (0.80–1.12) | 0.89 (0.69–1.16) | 1.09 (0.85–1.40) | 0.89 (0.75–1.06) |
High-Density Lipoprotein† | 0.94 (0.82–1.08) | 0.99 (0.79–1.23) | 0.93 (0.75–1.14) | 0.93 (0.80–1.09) |
Agatston Coronary Calcium | 1.19 (1.06–1.33) | 1.05 (0.83–1.32) | 1.29 (1.05–1.59) | 1.18 (1.03–1.35) |
For continuous risk-factors, the unit of difference was 1SD, except for age where it was 5 years. All Risk-Ratios are adjusted for age, sex and time interval between MR scans.
Additionally adjusted for use of lipid lowering medication